Cargando…
Ticagrelor monotherapy after CABG—Probably not at all and definitely not forever
Autores principales: | Sandner, Sigrid, Redfors, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322319/ https://www.ncbi.nlm.nih.gov/pubmed/35396762 http://dx.doi.org/10.1111/jocs.16503 |
Ejemplares similares
-
Commentary: Ticagrelor monotherapy—Not for CABG?
por: Sandner, Sigrid, et al.
Publicado: (2022) -
Antiplatelet therapy around CABG: the latest evidence
por: Sandner, Sigrid, et al.
Publicado: (2023) -
Every Fifteen Days Forever?
por: Noris, Marina, et al.
Publicado: (2022) -
Commentary: Nothing lasts forever
por: Mainwaring, Richard D.
Publicado: (2021) -
Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
por: Johnson, Thomas W., et al.
Publicado: (2020)